Cardiology FDA Approved

Impella CP with SmartAssist: A Newly FDA Approved Heart Pump with Optical Positioning Sensor

Abiomed, the maker of popular left ventricular assist devices, is releasing its newly FDA approved Impella CP with SmartAssist device. The pump features an optical sensor that physicians can use to position and reposition the device without relying on a cath lab, X-ray, or ultrasound imaging. The sensor can be used either during initial implantation of the pump or while the patient is in the ICU, if necessary.

The pump can deliver up to 4.3 liters of blood per minute, which is about 85% of a normal full cardiac cycle, all while providing real-time information on an accompanying controller about important hemodynamic numbers such as left ventricular end-diastolic pressure (LVEDP), mean arterial pressure (MAP), and cardiac power output (CPO).

“Access to real-time clinical data has allowed our team to identify best practices for patient management and weaning,” in a published statement said Hiram Bezerra, interventional cardiologist, University Hospitals, Cleveland. “Metrics such as LVEDP, MAP and CPO and the ability to monitor trends on the Impella console allow physicians to utilize this hemodynamic information to optimize heart recovery with objective and quantifiable data to enable clear communication within the shock team.”

Product page: Impella CP with SmartAssist…

Via: Abiomed…


Original Article: (

Written by